Ion Torrent

Guilford, United States Founded: 2007 • Age: 19 yrs Acquired By Life Technologies
Next-generation sequencing is enabled by semiconductor technology for DNA analysis.

About Ion Torrent

Ion Torrent is a Healthcare company based in Guilford (United States) founded in 2007 by Jonathan Rothberg, and was acquired by Life Technologies in August 2010. Next-generation sequencing is enabled by semiconductor technology for DNA analysis. It operates in the Healthcare and Technology sectors. Ion Torrent has raised $37.06 million across 1 funding round from investors including Life Technologies. Its chief executive, as recorded, is Jonathan Rothberg. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity is Ion Torrent Systems Inc. Its competitors include Cepheid, PacBio and Fluidigm; 3 of its 3 listed competitors have raised funding.

Company details

Ion Torrent was founded in 2007 in Guilford, United States, focusing on biotechnology tools for next-generation sequencing. A proprietary platform was developed, employing a sequencing-by-synthesis method that detects hydrogen ion release during DNA ligation via an ISFET sensor. Operations centered on genome sequencing advancements. The company was acquired by Life Technologies for 725 million in August 2010, and subsequently by Thermo Fisher Scientific in 2013.

  • Headquarters Guilford, United States
  • Founders Jonathan Rothberg
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Website iontorrent.com
  • Social LinkedIn X
  • Acquired by Life Technologies (Aug 2010)
  • Legal Name Ion Torrent Systems Inc
Key Metrics

Funding Insights of Ion Torrent

Ion Torrent has successfully raised a total of $37.06M through 1 strategic funding round. The most recent funding activity was a Series C round of $37.06 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $37.06M
  • Total Rounds 1
  • Last Round Series C β€” $37.06M
  • First Round $37.06M

    (Mar 2010)

All 1 funding rounds of Ion Torrent with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2010$37.06MSeries C––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Ion Torrent

Ion Torrent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Life Technologies.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Tools and technologies for biotech and biopharma research were supplied.
1983lifetechnologies.comCarlsbad, United States
Premium access

Investor details for Ion Torrent

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ion Torrent

1 people are tracked at Ion Torrent (1 in leadership).

NameRoleGroup
Jonathan Rothberg
Founder & CEOLeadership
Premium access

Complete people profiles for Ion Torrent

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ion Torrent

3 dated milestones of Ion Torrent across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ion Torrent is founded.
  2. Funding First funding round of $37.1M.
  3. Exit Acquired by Life Technologies.

Competitors of Ion Torrent

Ion Torrent has 3 listed competitors in our database, 3 of them funded. They include Cepheid, PacBio and Fluidigm.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
pacb.com2004Menlo Park, United States$395M649
Instrument systems and software for single-molecule real-time sequencing are developed.
fluidigm.com1999San Francisco, United States$40.53M205
Instruments for life sciences research and applications are developed.
Premium access

Detailed competitors of Ion Torrent

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Ion Torrent (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ion Torrent

Premium access

Complete news archive for Ion Torrent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ion Torrent

Ion Torrent was founded in 2007 and raised its 1st funding round 3 years after it was founded.

Ion Torrent is headquartered in Guilford, United States. It is registered at Guilford, Connecticut, United States.

Jonathan Rothberg is the CEO of Ion Torrent, as recorded in our data. They have also founded this company.

Ion Torrent is a funded company, having raised a total of $37.06M across 1 funding round to date. The company's 1st funding round was a Series C of $37.06M, raised on Mar 2010.

Ion Torrent was founded in 2007 in Guilford, United States, focusing on biotechnology tools for next-generation sequencing. A proprietary platform was developed, employing a sequencing-by-synthesis method that detects hydrogen ion release during DNA ligation via an ISFET sensor. Operations centered on genome sequencing advancements. The company was acquired by Life Technologies for 725 million in August 2010, and subsequently by Thermo Fisher Scientific in 2013.

Ion Torrent's top competitors include Cepheid, PacBio and Fluidigm.

Ion Torrent has 1 investor. Key investors include Life Technologies.

Ion Torrent operates through Ion Torrent Systems Inc.

Yes. Ion Torrent was acquired by Life Technologies in August 2010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available